Navalign, LLC Amgen Inc Transaction History

Navalign, LLC

$337 Million
Q3 2024

A detailed history of Navalign, LLC transactions in Amgen Inc stock. As of the latest transaction made, Navalign, LLC holds 22,982 shares of AMGN stock, worth $6.05 Million. This represents 2.2% of its overall portfolio holdings.

Number of Shares

22,982

Previous 22,781 0.88%

Holding current value

$6.05 Million

Previous $7.12 Million 4.05%

% of portfolio

2.2%

Previous 2.26%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $62,185 - $67,813	201 Added 0.88%	22,982 $7.41 Million
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $438,004 - $532,289	-1,667 Reduced 6.82%	22,781 $7.12 Million
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $12,905 - $15,578	-48 Reduced 0.2%	24,448 $6.95 Million
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $7,159 - $8,076	28 Added 0.11%	24,496 $7.06 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $122,225 - $151,746	559 Added 2.34%	24,468 $6.58 Million
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $1,285 - $1,520	6 Added 0.03%	23,909 $5.31 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $25,684 - $30,092	-121 Reduced 0.5%	23,903 $5.08 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $5,138 - $5,701	-22 Reduced 0.09%	24,024 $5.86 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $5.34 Million - $6.22 Million	24,046 New	24,046 $5.98 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.

Account